PROVECTUS BIOPHARMACEUTICALS, INC. Reports annual revenue of $557.7 thousand
Company Records $3.1 million loss
By USInMinutes
Published - Apr 04, 2024, 07:44 AM ET
Last Updated - Apr 04, 2024, 07:44 AM EDT
PROVECTUS BIOPHARMACEUTICALS, INC. [PVCTW] has reported $557.7 thousand in revenue for year ended Dec 31, 2023.
The company said in a filing before the Securities and Exchange Commission that its loss for the year was $3.1 million.
